Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combination of a Dermocosmetic and a Tainted Sunscreen Reduce Acne Severity and Signs of Post-inflammatory Hyperpigmentation in Subjects With a Fitzpatrick Phototype Ranging From IV to VI

NCT05601960 is registered in ClinicalTrials.gov with Cosmetique Active International as lead sponsor.

NCT NCT05601960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combination of a Dermocosmetic and a Tainted Sunscreen Reduce Acne Severity and Signs of Post-inflammatory Hyperpigmentation in Subjects With a Fitzpatrick Phototype Ranging From IV to VI
Lead sponsor
Cosmetique Active International
Phase
Observational
Overall status
Completed
Start date
April 15, 2020
Completion date
February 28, 2021
Enrollment
1,785 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne, postinflammatory hyperpigmentation